[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@fabitrades Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::248619799.png) @fabitrades Fabi Trades

Fabi Trades posts on X about market cap, $xcur, gainers, $vor the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::248619799/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::248619799/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX +16%
- X Year XXXXXXX +306%

### Mentions: XX [#](/creator/twitter::248619799/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::248619799/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XXX -XX%
- X Months XXX +93%
- X Year XXX +261%

### Followers: XXXXX [#](/creator/twitter::248619799/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::248619799/c:line/m:followers.svg)

- X Week XXXXX +0.13%
- X Month XXXXX +1.40%
- X Months XXXXX +19%
- X Year XXXXX +81%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::248619799/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::248619799/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[cryptocurrencies](/list/cryptocurrencies)  XXXXX% [finance](/list/finance)  XXXX% [countries](/list/countries)  XXXX%

**Social topic influence**
[market cap](/topic/market-cap) #679, [$xcur](/topic/$xcur) #77, [gainers](/topic/gainers) #35, [$vor](/topic/$vor) #16, [$ncpl](/topic/$ncpl) #53, [$snti](/topic/$snti) #17, [$nct](/topic/$nct) #12, [nct](/topic/nct) 6.67%, [$lghl](/topic/$lghl) 3.33%, [bitcoin](/topic/bitcoin) XXXX%

**Top assets mentioned**
[Curate (XCUR)](/topic/$xcur) [PolySwarm (NCT)](/topic/$nct) [Bitcoin (BTC)](/topic/bitcoin) [c8ntinuum (CTM)](/topic/$ctm)
### Top Social Posts
Top posts by engagements in the last XX hours

"Small Cap Gainers Pre-Market Lion Group Holding Ltd. ADR - $LGHL - 🏭 Sector: Financial - Capital Markets 💰 Market Cap: 0.92M 💸 Float: - / 6.59M Shares Outstanding 📰 News: Lion Group Holding Ltd. closed a $XXXXX million private placement via convertible notes and will allocate $X million of the net proceeds to purchase Bitcoin for its corporate treasury viewing current market conditions as a favorable entry point and seeking to diversify from its HYPE holdings with a liquid institutionally recognized asset. The transaction is expected to close on or about December X 2025. Company Profile:"  
[X Link](https://x.com/fabitrades/status/1996921978624573711)  2025-12-05T12:37Z 1517 followers, XXX engagements


"Good morning Small Caps on the move pre-market: $XCUR +65% $VOR +40% $NCPL +35% $SNTI +26% $GIPR +11%"  
[X Link](https://x.com/fabitrades/status/1998363905782096261)  2025-12-09T12:07Z 1516 followers, XXX engagements


"Small Cap Gainers Pre-Market Rani Therapeutics Holdings Inc. - $RANI - Sector: Healthcare - Biotechnology Market Cap: 33.84M Float: 35.99M News: Rani Therapeutics announced a collaboration with Chugai Pharmaceutical to develop an oral rare disease antibody using RaniPill technology with a $XX million upfront payment up to $XX million in development milestones $XXX million in sales milestones and royalties. Chugai can extend the deal to five more targets potentially totaling $XXXXX billion. Rani also secured a $XXXX million private placement extending its cash runway into 2028"  
[X Link](https://x.com/fabitrades/status/1979148733116731412)  2025-10-17T11:33Z 1514 followers, XXX engagements


"Small Cap Gainers Pre-Market Catellum Inc. - $CTM - Sector: Technology - Information Technology Services Market Cap: 106.95M Float: 67.59M News: Castellum Inc. reported record Q3 2025 revenue of $XXXX million up XX% YoY with third consecutive organic growth quarter achieving first-ever GAAP net income of $XXX million and adjusted EBITDA of $XXX million amid cost discipline. Cash hit a record $XXXX million with debt cut to $XXX million. CEO Glen Ives emphasized momentum from prime contracts product investments and M&A for long-term scaling while CFO David Bell noted enhanced liquidity for"  
[X Link](https://x.com/fabitrades/status/1986778159233306735)  2025-11-07T12:50Z 1514 followers, XXX engagements


"Small Caps on watch for market open: $AHMA $QTTB $NCT $FTEL $KALA $DYAI Wish you all a great last month of trading 2025🍀"  
[X Link](https://x.com/fabitrades/status/1995497470554689680)  2025-12-01T14:17Z 1516 followers, XXX engagements


"Small Cap Gainers Pre-Market Intercont (Cayman) Ltd. - $NCT - 🏭 Sector: Industrials - Marine Shipping 💰 Market Cap: 22.77M 💸 Float: 1.73M 📰 News: Intercont Limiteds Singapore subsidiary has entered a strategic ro-ro vessel partnership with CINCO INTERNATIONAL HONGKONG LIMITED. The deal adds low-carbon high-efficiency roll-on/roll-off ships to NCTs fleet takes over existing multi-year time charters and is projected to generate $XXXXXX million in cumulative revenue and $XXXXX million in net profit. The transaction supports NCTs carbon-neutral strategy while providing stable long-term cash"  
[X Link](https://x.com/fabitrades/status/1995499178131140709)  2025-12-01T14:24Z 1516 followers, XXX engagements


"Small Cap Gainers Pre-Market Above Food Ingredients Inc. - $ABVE - 🏭 Sector: Consumer Defensive - Packaged Foods 💰 Market Cap: 134.63M 💸 Float: 47.89M 📰 News: Above Food Ingredients Inc. reports its audit is progressing toward completion and Form 20-F filing by December XX 2025 with a new auditor specialized in digital asset tokenization. The company has eliminated all corporate debt through restructuring with Palm Global positioning it for over $XX million in profit for the fiscal year ending January XX 2026. Merger integration is accelerating with strengthened executive collaboration"  
[X Link](https://x.com/fabitrades/status/1994409997648711973)  2025-11-28T14:16Z 1517 followers, XXX engagements


"Small Cap Gainers Pre-Market Ekso Bionics Holdings Inc. - $EKSO - 🏭 Sector: Healthcare - Medical Instruments & Supplies 💰 Market Cap: 15M 💸 Float: 3.13M 📰 News: Ekso Bionics has signed an exclusive agreement to become the sole U.S. distributor of MediTouchs BalanceTutor a unique 4D perturbation treadmill system that safely simulates slips trips and stumbles to train reactive balance responses in rehabilitation settings. The partnership expands Eksos portfolio with a complementary technology targeting the same inpatient and outpatient rehab facilities. Company Profile: Ekso Bionics"  
[X Link](https://x.com/fabitrades/status/1996564388002631918)  2025-12-04T12:56Z 1516 followers, XXX engagements


"Small Cap Gainers Pre-Market Akanda Corp. - $AKAN - 🏭 Sector: Healthcare - Drug Manufacturers 💰 Market Cap: 0.69M 💸 Float: 0.73M 📰 News: No news. Company Profile: Akanda Corp. operates an international medical cannabis and wellness platform focused on cultivating processing and distributing cannabis products primarily for regulated medical markets and consumers"  
[X Link](https://x.com/fabitrades/status/1996920160574156926)  2025-12-05T12:30Z 1515 followers, XXX engagements


"Small Cap Gainers Pre-Market Cemtrex Inc. - $CETX - 🏭 Sector: Technology - Software - Infrastructure 💰 Market Cap: 2.09M 💸 Float: 0.67M 📰 News: No recent news. Had news on Nov-20th to acquire Invocon for $7.06M. Deal expected to close on or around January X 2026. Company Profile: Cemtrex Inc. is a multi-industry technology company that provides security and industrial services solutions including advanced video surveillance access control and industrial equipment installation and maintenance for commercial and government clients"  
[X Link](https://x.com/fabitrades/status/1998005802024497615)  2025-12-08T12:24Z 1515 followers, XXX engagements


"Small Cap Gainers Pre-Market Exicure Inc. - $XCUR - 🏭 Sector: Healthcare - Biotechnology 💰 Market Cap: 33.97M 💸 Float: 1.79M 📰 News: Exicure announced positive topline Phase X results for burixafor (GPC-100) in multiple myeloma presented at the 2025 ASH Annual Meeting. In the trial XXXX% of patients (17/19) achieved the primary endpoint of collecting X XX CD34+ cells/kg within two apheresis sessions when combined with propranolol and G-CSF. The regimen was well-tolerated with no drug-related adverse events above Grade X. Notably XXXX% of daratumumab-pretreated patients still met the"  
[X Link](https://x.com/fabitrades/status/1998368133359325558)  2025-12-09T12:24Z 1515 followers, XXX engagements


"Small Caps on watch for market open: $XCUR $NCPL $VOR $SNTI $ATMV $QCLS GLHF 🍀"  
[X Link](https://x.com/fabitrades/status/1998397924045176981)  2025-12-09T14:22Z 1519 followers, XXX engagements